Caffeine or other stimulants potentially included in the capsules or strips may cause jitteriness, anxiety, insomnia, or heart palpitations in sensitive individuals
The SUSTAIN-6 Trial (Once-Weekly Semaglutide) The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) consisted of 3297 people living with T2DM, 83% with established cardiovascular disease, receiving once-weekly semaglutide (0.5 and 1.0 mg) or placebo
Myth: More ingredients = better results. Fact: More ingredients can also mean more variables (tolerability, interactions, unclear dosing)
Microdosing GLP-1 helps calm appetite spikes, stabilize insulin response, and make body recomposition feel a bit more achievable without the heavy side effects that come with full medical doses
How does Wegovy work
Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia